作者: L. Oyejide , O.R. Mendes , I. Mikaelian
DOI: 10.1016/B978-0-12-803620-4.00016-5
关键词:
摘要: Abstract In this chapter, the preclinical applications of several molecular pathology technologies in advancing drug discovery and development are discussed, including immunohistochemistry, immunofluorescence, situ hybridization RNAScope, tissue microarrays, laser-capture microscopy, toxicogenomics, biomarkers, digital imaging, stereology, microRNA analysis. Examples provided to illustrate utility each specific technology for identification, characterization, elucidation pathogenetic mechanism(s) drug-related alterations.